jueves, 5 de agosto de 2021

EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19 | Annals of the Rheumatic Diseases

EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19 | Annals of the Rheumatic Diseases

No hay comentarios:

Publicar un comentario